guest ::
000478837 001__ 478837 000478837 005__ 20201223144436.0 000478837 0247_ $$2doi$$a10.1007/s00213-014-3794-9 000478837 0247_ $$2WOS$$aWOS:000352786900010 000478837 0247_ $$2pmid$$apmid:25373869 000478837 0247_ $$2BIOSIS$$aPREV201500419829 000478837 0247_ $$2ISSN$$a0033-3158 000478837 0247_ $$2ISSN$$a1432-2072 000478837 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-84939938916 000478837 037__ $$aRWTH-2015-02733 000478837 041__ $$aEnglish 000478837 082__ $$a610 000478837 1001_ $$0P:(DE-82)076647$$aVeselinovic, Tanja$$b0$$eCorresponding author 000478837 245__ $$aEffects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers$$honline, print 000478837 260__ $$aBerlin$$bSpringer$$c2015 000478837 3367_ $$00$$2EndNote$$aJournal Article 000478837 3367_ $$2DRIVER$$aarticle 000478837 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal 000478837 3367_ $$2BibTeX$$aARTICLE 000478837 3367_ $$2DataCite$$aOutput Types/Journal article 000478837 3367_ $$2ORCID$$aJOURNAL_ARTICLE 000478837 588__ $$aDataset connected to CrossRef 000478837 591__ $$aGermany 000478837 7001_ $$0P:(DE-82)014516$$aVernaleken, Ingo$$b1 000478837 7001_ $$0P:(DE-82)019279$$aJanouschek, Hildegard$$b2 000478837 7001_ $$0P:(DE-82)IDM03646$$aKellermann, Thilo$$b3$$urwth 000478837 7001_ $$0P:(DE-82)028941$$aPaulzen, Michael$$b4 000478837 7001_ $$0P:(DE-82)052424$$aCumming, Paul$$b5 000478837 7001_ $$0P:(DE-82)012827$$aGründer, Gerhard$$b6 000478837 773__ $$0PERI:(DE-600)2066933-1$$a10.1007/s00213-014-3794-9$$n9$$p1607-1617$$tPsychopharmacology$$v232$$x1432-2072$$y2015 000478837 909CO $$ooai:publications.rwth-aachen.de:478837$$pVDB 000478837 9141_ $$y2015 000478837 9151_ $$0StatID:(DE-HGF)0031$$2HGFVOC$$aPeer reviewed article$$x0 000478837 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPSYCHOPHARMACOLOGY : 2014 000478837 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS 000478837 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline 000478837 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database 000478837 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List 000478837 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index 000478837 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection 000478837 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded 000478837 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences 000478837 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews 000478837 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5 000478837 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz 000478837 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPSYCHOPHARMACOLOGY : 2015 000478837 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search 000478837 9201_ $$0I:(DE-82)535500-2_20140620$$k535500-2$$lLehrstuhl für Psychiatrie, Psychotherapie und Psychosomatik$$x0 000478837 9201_ $$0I:(DE-82)535500-4_20140620$$k535500-4$$lLehr- und Forschungsgebiet Experimentelle Psychopathologie$$x1 000478837 9201_ $$0I:(DE-82)535500-3_20140620$$k535500-3$$lLehr- und Forschungsgebiet Experimentelle Neuropsychiatrie$$x2 000478837 961__ $$c2015-06-03T11:07:38.379826$$x2015-06-03T11:07:38.379826$$z2015-06-09 000478837 980__ $$ajournal 000478837 980__ $$aVDB 000478837 980__ $$aI:(DE-82)535500-2_20140620 000478837 980__ $$aI:(DE-82)535500-4_20140620 000478837 980__ $$aUNRESTRICTED 000478837 980__ $$aI:(DE-82)535500-3_20140620